https://www.selleckchem.com/pr....oducts/camostat-mesi
Implications for clinical training and future research are discussed. This study evaluated the arrhythmia profile and ablation outcome in women with atrial fibrillation (AF) aged ≥75 years. A total of 573 consecutive female patients undergoing first AF ablation were classified into group 1 ≥75 years (n=221) and group 275 years (n=352). Isolation of PVs, posterior wall and superior vena cava was performed in all. Non-PV triggers from other areas were ablated based on operator's discretion. Group 1 had higher prevale
Like
Comment
Share
